Showing results (281-290 of 512) with videos related to
Sort By:
Pageof 52
Rheumatology and Therapy|July 8, 2018
Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional StudyKurt de Vlam, Joseph F Merola, Julie A Birt, et al.Lupus Science & Medicine|April 11, 2015
Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaireJ F Merola, F Nyberg, F Furukawa, et al.The Journal of Rheumatology|May 1, 2023
Sleep Problems in Patients With Psoriatic Arthritis: A Systematic Literature Review and MetaanalysisCarly Grant, Michael Woodbury, Marie Skougaard, et al.The Journal of Dermatological Treatment|April 18, 2024
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trialsJoseph F Merola, April Armstrong, Saakshi Khattri, et al.Journal of the American Academy of Dermatology|September 21, 2021
Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United StatesJoseph F Merola, Haijun Tian, Dhaval Patil, et al.Journal of the American Academy of Dermatology|April 3, 2018
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trialKim A Papp, Joseph F Merola, Alice B Gottlieb, et al.Journal of Drugs in Dermatology : JDD|June 5, 2023
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus PanelDanny Zakria, Nicholas Brownstone, April W Armstrong, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2026
Mapping malignant T-cell states and immune circuits in Sézary syndrome by single-cell analysisBeth A Childs, Eslam A Elghonaimy, Praveen Ramakrishnan Geethakumari, et al.The Journal of Dermatological Treatment|March 9, 2026
Bimekizumab efficacy in scalp, nail and palmoplantar psoriasis versus comparators and over 4 yearsPaolo Gisondi, Boni Elewski, Andreas Pinter, et al.Journal of the American Academy of Dermatology|March 6, 2024
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trialsAndrew Blauvelt, April Armstrong, Joseph F Merola, et al.Pageof 52